We can't find the internet
Attempting to reconnect
Something went wrong!
Hang in there while we get back on track
Lactiplantibacillus plantarum PD01 supplementation reduces microplastics and microplastic-associated chemicals in humans: A randomized, double-blind, placebo-controlled trial
AI summary Read the abstract
In a randomized, double-blind, placebo-controlled trial, 106 participants took Lactiplantibacillus plantarum PD01 or a placebo three times a day. Urinary phthalate metabolites were the first measure analyzed, and they fell by roughly 35 to 60% after six weeks in the probiotic group.
Abstract Plastic products have greatly improved convenience in daily life. However, diverse pollutants released from these materials pose substantial risks to human health. Lactiplantibacillus plantarum PD01 has previously been demonstrated to reduce microplastic (MP) bioaccumulation and toxicity in murine model. In this study, we conducted a randomized, double-blind, placebo-controlled trial to further evaluate the efficacy of L. plantarum PD01 in reducing MPs and MP-associated chemicals in humans. A total of 106 participants were recruited in November 2025. Eligible participants were randomly assigned to either the placebo or intervention group, and orally received placebo or 1.0×10 10 colony-forming units (CFU) L. plantarum PD01 after meals three times a day, respectively. Fecal, urinary, and blood samples were collected to determine the MPs contents, plasticizer levels, gut microbiota composition, blood metabolic profiles and biochemical indicators. Among these measurements, the analysis of urinary phthalate metabolites was completed first and revealed a significant reduction after the probiotic intervention. Compared with the placebo group, 6-week L. plantarum PD01 supplementation resulted in significant relative reductions in urinary levels of MCMHP by 60.2% ( P = 0.0343), MMP by 51.2% ( P < 0.001), MEHP by 49.6% ( P = 0.0058), MiBP by 45.7% ( P = 0.0085), MnBP by 35.8% ( P = 0.0478), and ΣDEHP by 46.2% ( P = 0.0461). The interim results presented here provide the first clinical evidence that the probiotic strain PD01 can significantly reduce residual MP-associated chemicals in human body. To the best of our knowledge, this is the first randomized controlled trial (RCT) to evaluate probiotic intervention targeting MPs and MP-associated chemicals in humans.
More Papers Like This
Lactiplantibacillus plantarum PD01 from high excretion donor functions as a natural defense against microplastic toxicity
AI summary Read the abstract
In 138 people, the amount of microplastic found in stool varied with the abundance of the gut bacterium Lactiplantibacillus plantarum. Researchers isolated strain PD01 and gave it to mice on a mixed microplastic diet. Treated mice had 50 to 91% less of four plastics remaining in the intestinal tract, depending on the polymer.
Lactiplantibacillus plantarum P101 Alleviates Liver Toxicity of Combined Microplastics and Di-(2-Ethylhexyl) Phthalate via Regulating Gut Microbiota
AI summary Read the abstract
Researchers found that the probiotic Lactiplantibacillus plantarum P101 reduced liver damage caused by combined exposure to microplastics and the plasticizer DEHP in mice. The probiotic reversed oxidative stress and inflammation in the liver and intestines while reshaping the gut microbiota. The study suggests that probiotic supplementation may offer a promising strategy for mitigating the toxic effects of co-exposure to microplastics and plastic-associated chemicals.
Lactobacillus plantarum reduces polystyrene microplastic induced toxicity via multiple pathways: A potentially effective and safe dietary strategy to counteract microplastic harm
AI summary Read the abstract
Mice exposed to polystyrene microplastics were given Lactobacillus plantarum strains that differed in antioxidant activity and in how well they bind the particles. Mice given strong binders had less polystyrene in the body and more in feces. A weakly binding strain also lowered toxicity, apparently through the intestinal barrier and bile acid metabolism.
Investigating the modulation of the endocannabinoid system by probiotic Lactiplantibacillus plantarum IMC513 in a zebrafish model of di-n-hexyl phthalate exposure
AI summary Read the abstract
Researchers found that a probiotic strain (Lactiplantibacillus plantarum IMC513) protected zebrafish from neurological disruption caused by di-n-hexyl phthalate, a plasticizer chemical used in food packaging, by restoring normal gene expression in the brain's endocannabinoid signaling system. This suggests probiotics may help counteract the brain and gut effects of phthalate exposure from plastic products.
Lactiplantibacillus plantarum as a Biosafe Microbial Bridge in the Gut–Environment Continuum
AI summary Read the abstract
This review summarizes existing research on a bacterium called Lactiplantibacillus plantarum, which has been studied for roles in soil and water cleanup, agriculture, and fermented foods. Some strains were reported to bind metals like lead and cadmium and to affect microplastic-related toxicity, though the authors note these effects vary by strain and need more testing before real-world use.
Research digests by email
When a large batch of papers lands in the Atlas, we read through it and send a short write-up of what stood out.